Cello Group plc (LON:CLL) announced a dividend on Wednesday, September 20th, Upcoming.Co.Uk reports. Investors of record on Thursday, October 5th will be given a dividend of GBX 1.05 ($0.01) per share on Friday, November 3rd. This represents a yield of 0.81%. The ex-dividend date of this dividend is Thursday, October 5th. The official announcement can be seen at this link.

Cello Group plc (LON CLL) traded up 0.98% during mid-day trading on Friday, reaching GBX 130.00. The company had a trading volume of 23,096 shares. The company’s 50-day moving average is GBX 124.95 and its 200-day moving average is GBX 126.43. The stock’s market capitalization is GBX 134.77 million. Cello Group plc has a one year low of GBX 94.60 and a one year high of GBX 140.00.

ILLEGAL ACTIVITY NOTICE: “Cello Group plc (CLL) Announces GBX 1.05 Dividend” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/09/30/cello-group-plc-cll-announces-gbx-1-05-dividend.html.

In other news, insider Mark Bentley acquired 110,000 shares of Cello Group plc stock in a transaction on Wednesday, September 27th. The stock was acquired at an average cost of GBX 128 ($1.72) per share, with a total value of £140,800 ($189,349.11).

Several brokerages have weighed in on CLL. FinnCap reissued a “buy” rating and set a GBX 132 ($1.78) price objective on shares of Cello Group plc in a report on Tuesday. N+1 Singer reissued a “buy” rating and set a GBX 131 ($1.76) price objective on shares of Cello Group plc in a report on Wednesday, September 20th.

About Cello Group plc

Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients.

Dividend History for Cello Group plc (LON:CLL)

Receive News & Stock Ratings for Cello Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Group plc and related stocks with our FREE daily email newsletter.